AAAAAA
Results:
1-8
|
Results: 8
Authors:
Cochand-Priollet, B
Le Gales, C
de Cremoux, P
Molinie, V
Sastre-Garau, X
Vacher-Lavenu, MC
Vielh, P
Coste, J
Citation: B. Cochand-priollet et al., Cost-effectiveness of monolayers and human papillomavirus testing comparedto that of conventional Papanicolaou smears for cervical cancer screening:Protocol of the study of the French Society of Clinical Cytology, DIAGN CYTOP, 24(6), 2001, pp. 412-420
Authors:
de Cremoux, P
Extra, JM
Denis, MG
Pierga, JY
Bourstyn, E
Nos, C
Clough, KB
Boudou, E
Martin, EC
Muller, A
Pouillart, P
Magdelenat, H
Citation: P. De Cremoux et al., Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction, CLIN CANC R, 6(8), 2000, pp. 3117-3122
Authors:
Janoueix-Lerosey, I
Penther, D
Thioux, M
de Cremoux, P
Derre, J
Ambros, P
Vielh, P
Benard, J
Aurias, A
Delattre, O
Citation: I. Janoueix-lerosey et al., Molecular analysis of chromosome arm 17q gain neuroblastoma, GENE CHROM, 28(3), 2000, pp. 276-284
Authors:
Vincent-Salomon, A
Carton, M
Freneaux, P
Palangie, T
Beuzeboc, P
Mouret, E
de Cremoux, P
Coue, O
Zafrani, B
Nicolas, A
Clough, K
Fourquet, A
Pouillart, P
Sastre-Garau, X
Citation: A. Vincent-salomon et al., ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy, EUR J CANC, 36(5), 2000, pp. 586-591
Authors:
Zafrani, B
Aubriot, MH
Mouret, E
de Cremoux, P
de Rycke, Y
Nicolas, A
Boudou, E
Vincent-Salomon, A
Magdelenat, H
Sastre-Garau, X
Citation: B. Zafrani et al., High sensitivity and specificity of immunohistochemistry for the detectionof hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases, HISTOPATHOL, 37(6), 2000, pp. 536-545
Authors:
de Cremoux, P
Salomon, AV
Liva, S
Dendale, R
Bouchind'homme, B
Martin, E
Sastre-Garau, X
Magdelenat, H
Fourquet, A
Soussi, T
Citation: P. De Cremoux et al., p53 mutation as a genetic trait of typical medullary breast carcinoma, J NAT CANC, 91(7), 1999, pp. 641-643
Authors:
de Cremoux, P
Martin, EC
Vincent-Salomon, A
Dieras, V
Barbaroux, C
Liva, S
Pouillart, P
Sastre-Garau, X
Magdelenat, H
Citation: P. De Cremoux et al., Quantitative pcr analysis of c-erb B-2 (HER2/neu) gene amplification and comparison with p185(HER2/neu) protein expression in breast cancer drill biopsies, INT J CANC, 83(2), 1999, pp. 157-161
Authors:
Beuzeboc, P
Scholl, S
Garau, XS
Vincent-Salomon, A
de Cremoux, P
Couturier, J
Palangie, T
Pouillard, P
Citation: P. Beuzeboc et al., Herceptin, a monoclonal humanized antibody anti-HER2: a major therapeutic progress in breast cancers overexpressing this oncogene, B CANCER, 86(6), 1999, pp. 544-548
Risultati:
1-8
|